• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Investigation of Varicella zoster Virus Specific Immune Response for Prevention of Shingles in people with Diabetes.

Research Project

Project/Area Number 15K08759
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Epidemiology and preventive medicine
Research InstitutionThe Tazuke Kofukai

Principal Investigator

HATA Atsuko  公益財団法人田附興風会, 医学研究所 第4研究部, 研究主幹 (70321685)

Project Period (FY) 2015-04-01 – 2018-03-31
Project Status Completed (Fiscal Year 2017)
Budget Amount *help
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2017: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2016: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2015: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Keywords水痘帯状疱疹ワクチン / 糖尿病 / 細胞性免疫 / 液性免疫 / IFN-γ アッセイ / 同時接種 / 23価肺炎球菌ワクチン / 帯状疱疹 / 水痘ワクチン / 二重盲検比較試験 / 高齢者 / 二重盲検プラセボ対照ランダム化比較試験 / IFNγアッセイ / 水痘帯状疱疹ウイルス
Outline of Final Research Achievements

Cell-mediated immunity against live varicella-zoster vaccine with 23 valent pneumococcal polysaccharide vaccine simultaneously for people with diabetes aged 50 years or over resulted in a low response assessed by varicella-zoster virus (VZV) antigen skin test. We changed the method and found that VZV-specific cell-mediated immunity after varicella-zoster vaccination in healthy adults can be evaluated by whole blood IFN-γ assay by VZV antigen stimulation. A randomized double blind placebo-controlled trial with varicella-zoster vaccine and placebo in people with diabetes over the age of 50 years was conducted. VZV specific cell-mediated immunity was assessed by this whole blood IFN-γ assay and humoral immunity and safety to the varicella-zoster vaccine were also evaluated. 85 people were registered by June 2018, the final blood sampling one year after the last vaccination is scheduled to be completed in July 2018.

Report

(4 results)
  • 2017 Annual Research Report   Final Research Report ( PDF )
  • 2016 Research-status Report
  • 2015 Research-status Report
  • Research Products

    (9 results)

All 2018 2017 2016

All Journal Article (3 results) (of which Peer Reviewed: 3 results,  Acknowledgement Compliant: 1 results) Presentation (6 results) (of which Int'l Joint Research: 1 results,  Invited: 2 results)

  • [Journal Article] Herpes zoster meningitis in immunocompetent children: Two case reports and a literature review.2017

    • Author(s)
      Itoh N, Motokura K, Kumakura A, Hata D, Hata A.
    • Journal Title

      Pediatr Int.

      Volume: 59 Issue: 10 Pages: 1116-1118

    • DOI

      10.1111/ped.13362

    • Related Report
      2017 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Efficacy and safety of live varicella zoster vaccine in diabetes: a randomized, double-blind, placebo-controlled trial2016

    • Author(s)
      Hata A, Inoue F, Hamamoto Y, Yamasaki M, Fujikawa J, Kawahara H, Kawasaki Y, Honjo S, Koshiyama H, Moriishi E, Mori Y, Ohkubo T.
    • Journal Title

      Diabet Med.

      Volume: 33 Issue: 8 Pages: 1094

    • DOI

      10.1111/dme.13038

    • Related Report
      2016 Research-status Report
    • Peer Reviewed / Acknowledgement Compliant
  • [Journal Article] Vaccine-strain herpes zoster found in the trigeminal nerve area in a healthy child: A case report.2016

    • Author(s)
      Iwasaki S, Motokura K, Honda Y, Mikami M, Hata D, Hata A.
    • Journal Title

      J Clin Virol.

      Volume: 85 Pages: 44-47

    • DOI

      10.1016/j.jcv.2016.10.022

    • Related Report
      2016 Research-status Report
    • Peer Reviewed
  • [Presentation] 帯状疱疹と水痘ワクチン2018

    • Author(s)
      羽田敦子
    • Organizer
      第15回北大阪感染症研究会
    • Related Report
      2017 Annual Research Report
    • Invited
  • [Presentation] Humoral immunity to varicella zoster virus 7 years after varicella vaccination2017

    • Author(s)
      Atsuko Hata、 Kentaro Kato, Ryoko Akashi-Ueda, Kenji Nakagawa, Junya Abe, Sumie Yamashita, Akira Kumakura, Yui Itou, Toshihiko Nanbara, Takakazu Yoshioka, Hiroshi Mizumoto, Mitsutaka Shiota, Ken Watanabe, Daisuke Hata.
    • Organizer
      35th annual meeting of the ESPID. Madrid, Spain 23-27 May 2017
    • Related Report
      2017 Annual Research Report
    • Int'l Joint Research
  • [Presentation] 健常成人における水痘帯状疱疹ワクチンの細胞性免疫能増強2017

    • Author(s)
      羽田敦子、辻本考、加藤瑞樹、丸毛聡、上田覚、四茂野恵奈、菊池航紀、藤本卓司、秦大資、奥野壽臣
    • Organizer
      第91回日本感染症学会総会・学術講演会
    • Related Report
      2017 Annual Research Report
  • [Presentation] 予防接種に関しての最新のトピックス2017

    • Author(s)
      羽田敦子
    • Organizer
      東淀川区病診連携会講演会
    • Related Report
      2017 Annual Research Report
    • Invited
  • [Presentation] 健常成人における水痘帯状疱疹ワクチンの細胞性免疫能評価2016

    • Author(s)
      〇羽田敦子,榊原敦子,奥野壽臣
    • Organizer
      第20回日本ワクチン学会学術集会
    • Place of Presentation
      東京、京王プラザホテル
    • Year and Date
      2016-10-22
    • Related Report
      2016 Research-status Report
  • [Presentation] 高齢糖尿病患者における水痘帯状疱疹ワクチンランダム化二重盲検試験後の同時接種23価肺炎球菌多糖体ワクチン免疫応答解析2016

    • Author(s)
      ○羽田敦子,石岡大成,大石和徳
    • Organizer
      第90回日本感染症学会総会・学術講演会
    • Place of Presentation
      仙台市、仙台国際センター
    • Year and Date
      2016-04-16
    • Related Report
      2016 Research-status Report

URL: 

Published: 2015-04-16   Modified: 2019-03-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi